Hannes Becker

We had a wonderful #eano2025 in Prague, with multiple talks and poster presentations and fruitful discussions!
Looking forward to Rome!
@eanoassociation.bsky.social
@ghtabatabai.bsky.social
@hannes-becker1996.bsky.social
@nihalolcaydogan.bsky.social
@hih-tuebingen.bsky.social

Now Surender Surender on stage, presenting our data on CDK4/6 inhibition in experimental glioma!
@eanoassociation.bsky.social
@ghtabatabai.bsky.social
@hih-tuebingen.bsky.social

Great talk by @ghtabatabai.bsky.social about time management in academia
@eanoassociation.bsky.social

Glad to have the opportunity to present our data!
@eanoassociation.bsky.social

Nice opportunity to present our data on regorafenib in combination with navitoclax at @eanoassociation.bsky.social
@hannes-becker1996.bsky.social
@ghtabatabai.bsky.social

Great comprehensive talk by @ghtabatabai.bsky.social to give insights into CRISPR screen.
More to come!
@eanoassociation.bsky.social

Extremely happy that we could have contributed!

Innovative trial design, thank you for the opportunity for being part of it!

🧠 Recently published in Neuro-Oncology: EANS–EANO Guidelines on the Extent of Resection in Gliomas. We’re proud to share the outcome of collaborative effort by the joint task force of EANS and EANO, providing evidence-based recommendations for clinical practice.
🔗 academic.oup.com/neuro-oncolo...

Molecularly matched targeted therapies plus radiotherapy in glioblastoma: the phase 1/2a N2M2 umbrella trial - Nature Medicine In a phase 1/2a umbrella trial in patients with glioblastoma matching targeted therapies according to tumor molecular profiling, temsirolimus plus radiotherapy improved PFS compared to standard of car...

🧠 The phase 1/2 N2M2 umbrella trial lead by former EANO president @wickwolfgang.bsky.social has just been published in Nature Medicine
🔗 www.nature.com/articles/s41...

#NeuroOncology #EANOessentials #BrainTumors #CancerResearch

Glad to present our data at this years #DGNC2025

Thank you for having the opportunity to present our data at this year DGNC in Hanover.
#DGNC2025

Almost 25 year old T-shirt, reminds me of great experience at MGH/HMS 2000/2001, @harvard.edu - hard to see this institution under pressure now, and impressed by the integrity and resilience of Harvard leadership (more on LinkedIn) 🙌 #Harvard #AcademicFreedom #ScienceForDemocracy #ScienceMatters

Hoffnung fällt nicht vom Himmel.
Hoffnung ist harte Arbeit.
Heute, morgen, übermorgen.
Wir sind da. Und wir sind viele.

Thank you for your engagement Ghazaleh Tabatabai 🙏 #aufstehenfuerdemokratie

#aufstehenfuerdemokratie

Tübingen 12 Feb 2025
Geschwister Scholl Platz
Democracy needs facts
Science needs Democracy.
#aufstehenfuerdemokratie

📢 Es ist 5 vor 12❗

"Aufstehen für Demokratie" setzt sich für faktenbasierte politische Entscheidungen und Demokratie ein:
www.aufstehenfuerdemokratie.de
www.openpetition.de/!ychtb

📅 Sei dabei am 12.02 um 11:55 Uhr an Hochschulen und Forschungseinrichtungen

🔬 Wissenschaft braucht Demokratie 🤝

Great to see this finally out😍
Glad that I could contribute to this exciting Story!

@hih-tuebingen.bsky.social
@unituebingen.bsky.social

Happy that I could contribute to this fantastic work!
Check it out😉

Member Spotlight: Dr. Ghazaleh Tabatabai

@ghtabatabai is a neurologist and a physician scientist at the University of Tübingen and the Managing Director Neurology at the University Hospital Tübingen.

Her research includes target discovery & validation, molecular mechanisms of treatment resistance, & novel delivery routes to brain tumors.